2019 Annual Meeting | S30 - Brain Cancer: From Epidemiology to Quality of Life
Program Materials Program Evaluations
Na Tosha N. Gatson, MD, PhD, FAAN | Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities. |
Scott R. Plotkin, MD, PhD, FAAN | Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care. |
Maciej M. Mrugala, MD, PhD, MPH, FAAN | Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities. |
No disclosure on file | |
Deborah Forst, MD | Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant. |
Areej El-Jawahri | No disclosure on file |
Jane Chan, MD | No disclosure on file |
Joy E. Burke, MD | No disclosure on file |
Chinazom U. Ibegbu, MD | Dr. Ibegbu has nothing to disclose. |
Sylvia C. Kurz, MD, PhD | Dr. Kurz has received personal compensation in the range of $0-$499 for serving as a Consultant for Advanced Accelerator Applications. |
Jorg Dietrich, MD, PhD, FAAN | Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care. |
Jay-Jiguang Zhu, MD, PhD, FAAN | Dr. Zhu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure, INC, Japan. An immediate family member of Dr. Zhu has stock in Abbott lab. The institution of Dr. Zhu has received research support from NRG NIH. The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from Five Prime pharmaceutical. The institution of Dr. Zhu has received research support from Denovo, inc. The institution of Dr. Zhu has received research support from Boston Biomedical Sumitomo Dainippon Pharma Global Oncology. The institution of Dr. Zhu has received research support from CNS pharmaceutical. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc. |
Nimish A. Mohile, MD, FAAN | The institution of Dr. Mohile has received research support from Novocure. |
Roberto Ruda, MD | Dr. Ruda has nothing to disclose. |
Karisa C. Schreck, MD, PhD | Dr. Schreck has received personal compensation in the range of $0-$499 for serving as a Consultant for Nurix. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Schreck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra LLC. The institution of Dr. Schreck has received research support from Springworks Therapeutics. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a speaker with Springworks Therapeutics. |
Lauryn Hemminger | Dr. Hemminger has nothing to disclose. |
Iryna Leunikava | No disclosure on file |
Jessica F. Occhiogrosso | Ms. Occhiogrosso has nothing to disclose. |
Jennifer N. Serventi, PA | Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure. |
Marc De Backer, MD, FBCPM, MBA | No disclosure on file |
Asad Ali, MD | No disclosure on file |
Matthias Holdhoff | No disclosure on file |
Alona Muzikansky | No disclosure on file |
Catherine Garcia, MD | Dr. Garcia has nothing to disclose. |
Sebastian Friedrich Winter | Mr. Winter has nothing to disclose. |
Surabhi Ranjan, MD | Dr. Ranjan has nothing to disclose. |
Sharon Yu | No disclosure on file |
Bjorn Steiniger Brach | No disclosure on file |
Maria Martinez-Lage, MD | The institution of Dr. Martinez-Lage has received research support from NIH. |
Helen Shih | No disclosure on file |
Anas Ahmed Moahmmed Saeed Bamashmos, MD | No disclosure on file |